Free Newsletter
FDA preps to toughen up
Top among commissioner Margaret Hamburg's six steps towards a strong FDA are a 15-day post-inspection deadline for response by out-of-compliance companies, and then a formal close-out process in which the FDA certifies that the corrections have been made, both by letter and on its website (see previous item, "Hamburg pushes toward ‘strong FDA'").
The remaining steps involve actions to further ensure that violations are taken seriously and actions are quick. The regulator will speed up its process of issuing warning letters by limiting their review to "significant legal issues." As a result, most enforcement letters will enjoy a "more streamlined process. This approach is consistent with the FDA's longstanding historical practice," says Hamburg.
The FDA will also prioritize enforcement via such prompt follow-up as an inspection or investigation.
In addition, regulators will be "prepared to act swiftly and aggressively to protect the public." No more multiple warning letters prior to enforcement action. "If we find that we must move quickly to address significant health concerns or egregious violations," says Hamburg, "we will consider immediate action--even before we have issued a formal warning letter."
- see Hamburg's talk in a 25-minute web cast
- here's the text
Related Articles:
Hamburg 'honeymoon' could aid FDA reform
Can a tough, persuasive Hamburg overhaul FDA?
FDA wants to keep fewer secrets
FDA chiefs: We're for public health
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: